• Markets
    • icon
  • Companies
IIQ · ASX

Inoviq Ltd (ASX:IIQ)

AU$0.59

 0.0 (0.0%)
ASX:Live
01/12/2023 03:59:04 PM
HALO Ords HALO Consensus Value GROWTH AUS EMA 125 Breakdown All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IIQ Overview

IIQ Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About IIQ

Website

Inoviq Ltd

Telephone

61.3.9548.7586

Address

23 Normanby Road Notting Hill, Victoria (VIC) 3168

Description

INOVIQ Ltd. is a biotechnology company, which engages in the provision of medical services. Its activities include research and development of non-invasive diagnostic tests for early detection of cancer, based on certain proprietary intellectual property. The company was founded on June 30, 1983 and is headquartered in Subiaco, Australia.

IIQ Price Chart

Key Stats

Market Cap

AU$53.37M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.46 - 0.99

Trade Value (12mth)

AU$12,521.00

1 week

0.85%

1 month

0.85%

YTD

-7.81%

1 year

-6.35%

All time high

61.1211

Key Fundamentals

EPS 3 yr Growth

36.000%

EBITDA Margin

%

Operating Cashflow

-$7m

Free Cash Flow Return

-28.70%

ROIC

-36.70%

Interest Coverage

-151.60

Quick Ratio

6.20

Other Data

Shares on Issue (Fully Dilluted)

92m

HALO Sector

Healthcare

Next Company Report Date

27-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IIQ Announcements

Latest Announcements

Date Announcements

31 January 23

Appendix 4C & Quarterly Activities Report - December 2022

×

Appendix 4C & Quarterly Activities Report - December 2022

31 January 22

Appendix 4C & Quarterly Activities Report

×

Appendix 4C & Quarterly Activities Report

31 January 22

Notification regarding unquoted securities - IIQ

×

Notification regarding unquoted securities - IIQ

30 October 23

Appendix 4C and Quarterly Activities Report - September 2023

×

Appendix 4C and Quarterly Activities Report - September 2023

30 November 23

Initial Director's Interest Notice

×

Initial Director's Interest Notice

30 November 22

Change in substantial holding

×

Change in substantial holding

30 June 23

Notification of cessation of securities - IIQ

×

Notification of cessation of securities - IIQ

30 August 23

Appendix 4E and Preliminary Financial Report

×

Appendix 4E and Preliminary Financial Report

30 August 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 August 22

Appendix 4E and Preliminary Financial Report

×

Appendix 4E and Preliminary Financial Report

29 November 23

2023 AGM CEO Presentation

×

2023 AGM CEO Presentation

29 November 23

2023 AGM Results of Meeting

×

2023 AGM Results of Meeting

29 June 23

SubB2M/CA15.3 Clinical Validation Data Investor Presentation

×

SubB2M/CA15.3 Clinical Validation Data Investor Presentation

29 December 21

INOVIQ Appendix 4G and Corporate Governance Statement

×

INOVIQ Appendix 4G and Corporate Governance Statement

29 April 22

IIQ Appendix 4C & Quarterly Activities Report - March 2022

×

IIQ Appendix 4C & Quarterly Activities Report - March 2022

28 September 22

2022 Annual Report and update on results

×

2022 Annual Report and update on results

28 October 22

IIQ Appendix 4C & Quarterly Activities Report-September 2022

×

IIQ Appendix 4C & Quarterly Activities Report-September 2022

28 November 22

INOVIQ Settles Legal Proceedings

×

INOVIQ Settles Legal Proceedings

28 November 22

CEO AGM Presentation

×

CEO AGM Presentation

28 November 22

Results of 2022 Annual General Meeting

×

Results of 2022 Annual General Meeting

28 March 22

Update on Legal Proceedings and BARD1 Autoantibody Program

×

Update on Legal Proceedings and BARD1 Autoantibody Program

28 July 23

Appendix 4C and Quarterly Activities Report - June 2023

×

Appendix 4C and Quarterly Activities Report - June 2023

28 April 23

Appendix 4C and Quarterly Activities Report - March 2023

×

Appendix 4C and Quarterly Activities Report - March 2023

27 September 23

Notice required under Listing Rule 3.13.1

×

Notice required under Listing Rule 3.13.1

27 September 23

2023 Annual Report

×

2023 Annual Report

27 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

27 October 22

Notice of Annual General Meeting

×

Notice of Annual General Meeting

IIQ Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.14 -0.20 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.14 -0.20 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -101.3 -38.8 51.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.06 -0.05 -0.08 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.07 -0.07 -0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.9 11.5 -44.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -3.9 -17.9 -9.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.36 0.31 0.21 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.04 0.18 0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -74.4 397.0 -46.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 77 91 92 Lock Lock Lock
Basic m Lock Lock Lock Lock 77 91 92 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -40.9 43.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 7 9 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -3 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 45.4 44.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -736.7 -679.8 -261.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 837 780 361 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -6 -7 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -120.0 -10.5 -28.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,360.8 -2,542.3 -2,265.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -7 -9 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -151.5 -25.5 -14.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,555.2 -3,301.7 -2,615.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -15 -22 -10 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 -3 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -11 -18 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -242.7 -63.2 50.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,382.2 -6,575.0 -2,252.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -5 -6 -7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 3 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 17 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -6 -6 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -124.0 -11.7 -15.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -12.1 -22.9 -18.3 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 5 15 8 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 34 31 22 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 -14 -7 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 2 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 29 28 20 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 30 29 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 362.9 -3.5 -30.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -33.3 -59.1 -41.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.4 -64.3 -45.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -39.6 -30.7 -42.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -61.2 -61.8 -36.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -28.9 -20.6 -28.7 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -64.2 -85.8 -151.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.6 2.0 0.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -12.9 -50.9 -36.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.9 9.7 6.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.8 9.7 6.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 88.5 88.1 83.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -360.5 -337.5 -462.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.9 0.3 0.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 164.9 70.8 92.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.0 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 129.2 368.5 117.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -3,133.8 -7,794.5 -2,527.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -43.8 -70.1 -46.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -33.3 -59.1 -41.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.4 -64.3 -45.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -38.4 -64.3 -45.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 2.2 5.2 4.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 93.9 1,269.7 1,328.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 96.2 1,274.9 1,332.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 64.6 139.6 188.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 31.5 1,135.3 1,144.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IIQ Shortsell

Frequently Asked Questions

The current share price of Inoviq Ltd (IIQ:ASX) is AU$0.59.
The 52-week high share price for Inoviq Ltd (IIQ:ASX) is AU$0.99.
The 52-week low share price for Inoviq Ltd (IIQ:ASX)? is AU$0.46.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) has a franking level of 0%.
Inoviq Ltd (IIQ:ASX) is classified in the Healthcare.
The current P/E ratio for Inoviq Ltd (IIQ:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.